Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-002114
Filing Date
2025-04-01
Accepted
2025-04-01 17:00:26
Documents
19
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm   iXBRL DEF 14A 611668
2 formded14a_001.jpg GRAPHIC 17753
3 formdef14a_02.jpg GRAPHIC 51175
4 proxy_001.jpg GRAPHIC 297846
5 proxy_002.jpg GRAPHIC 239579
  Complete submission text file 0001641172-25-002114.txt   2678445

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE celc-20241231.xsd EX-101.SCH 6189
7 XBRL DEFINITION FILE celc-20241231_def.xml EX-101.DEF 10053
8 XBRL LABEL FILE celc-20241231_lab.xml EX-101.LAB 67401
9 XBRL PRESENTATION FILE celc-20241231_pre.xml EX-101.PRE 45651
21 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 65462
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Filer) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38207 | Film No.: 25800640
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)